Gastrointestinal discomfort : Common symptoms include nausea, GERD, slowed digestion, and constipation
Waivers for positive drug tests are rare, except perhaps for minor marijuana use, and only after evidence of rehabilitation
Figure 1 4.1.1 Cardiovascular outcomes in SGLT2 inhibitors: safety studies The EMPA-REG OUTCOME trial, which included 7020 patients with T2DM, was the first to demonstrate the cardiovascular protective effects of empagliflozin ( Subsequent trials, such as CANVAS and DECLARE-TIMI 58, have further confirmed the cardiovascular benefits of SGLT-2 inhibitors
Since every part of our body (our brain, skin, gut, and other organs) is affected by oxidative stress, glutathione is beneficial overall
Additionally, the treatment has shown the potential to aid in weight loss, with participants experiencing notable decreases in body weight during trials